annb0t
Top 20
Veracyte VCYT delivered a diluted loss of 2 cents per share in the first quarter of 2024 compared with a loss of 11 cents per share in the year-ago period. The reported figure is also narrower than the Zacks Consensus Estimate of a loss of 19 cents per share.
Revenues
Revenues reported in the first quarter increased 17.5% year over year to $96.8 million. The metric exceeded the Zacks Consensus Estimate by 3.3%.
Quarterly Details
Testing revenues were $90.3 million in the reported quarter, up...
>>> Read more: Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
Revenues
Revenues reported in the first quarter increased 17.5% year over year to $96.8 million. The metric exceeded the Zacks Consensus Estimate by 3.3%.
Quarterly Details
Testing revenues were $90.3 million in the reported quarter, up...
>>> Read more: Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
